Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
July 24, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
All Press Releases for November 3, 2004 Subscribe to this News Feed     Subscribe to this Podcast Feed  
 

Baxa Launches CyTwo-Fer Needle - Unique Dual-Purpose Device for Safe Reconstitution of Hazardous Drugs

Baxa Ltd. has launched the CyTwo-Fer Needle, featuring a unique hub design that provides vented access to vials or non-vented access to IV bags, performing the work of two devices. Both bags and vials may then be accessed in one procedure - avoiding the expense and time involved in changing needles. Designed to prevent environmental contamination during cytotoxic drug reconstitution, the CyTwo-Fer Needle has a 0.2 micron vent filter, allowing safe and efficient vial reconstitution, aspiration and subsequent injection of drugs into bags or other IV delivery devices.

Ascot, Berkshire (PRWEB) November 3, 2004 -- Baxa Ltd. announces the launch of the CyTwo-Fer Needle, featuring a unique hub design that provides vented access to vials or non-vented access to IV bags, performing the work of two devices. Both bags and vials may then be accessed in one procedure - avoiding the expense and time involved in changing needles.

The CyTwo-Fer Needle features a 16G stainless steel cannula with a Huber point for smooth and safe vial access, without the coring often associated with plastic spike devices. The Huber point also allows users to direct liquid flow into the vial to reduce foaming during admixture.

Designed to prevent environmental contamination during cytotoxic drug reconstitution, the CyTwo-Fer Needle has a 0.2 micron vent filter, allowing safe and efficient vial reconstitution, aspiration and subsequent injection of drugs into bags or other IV delivery devices. This filtered vent balances air pressure in the vial or container for fast and easy liquid addition and removal, minimising the risk of upper limb disorder. Finger grips and a tethered cap also facilitate ease of use.

"With this dual-purpose needle, Baxa makes the reconstitution process safer for technicians handling hazardous drugs," says Terry Aston, Managing Director for Baxa Ltd. "Its high-flow vent filter traps potentially harmful aerosol particles during reconstitution."

CyTwo-Fer Needles are available for sale now in Europe, the Middle East and Africa - directly through Baxa Ltd. or through dealer representatives. For more information, check the product section of http://www.baxa.com or contact Baxa Ltd.

Photos available on request.

About Baxa Corporation
As a leading provider of devices and systems for the preparation, handling, packaging, and administration of liquid medications, Baxa manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Baxa Ltd. is a wholly owned subsidiary of Baxa Corporation, headquartered in Englewood, Colorado. Baxa has locations in Canada, Denmark and Germany, and distribution partners worldwide. Further information is available at http://www.baxa.com.

Contact:
Stephanie Scott, Marketing Manager, Baxa Ltd.
Tel: +44 (0) 1344 890916 or Fax: +44 (0) 1344 890917
email: s.scott@baxa.co.uk

# # #

This press release was posted by the following PR Firm
Absolutely Public Relations (View Listing in Directory of PR Firms)
 
Other Releases by this Member
OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Maggie Holben
ABSOLUTELY PUBLIC RELATIONS
303-984-9801
Email us Here
ATTACHED FILES

CyTwo-Fer™ Needle
Unique Dual-Purpose Device for Safe Reconstitution of Hazardous Drugs

Baxa Corporation - Englewood, CO
Please do not alter image in any manner.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright